Skip to Main Content
Frequently Asked Questions
Submit an ETD
Global Search Box
Need Help?
Keyword Search
Participating Institutions
Advanced Search
School Logo
Files
File List
10570.pdf (2.11 MB)
ETD Abstract Container
Abstract Header
Modified Antibody for Targeted Drug Delivery and Reduced Immunogenicity
Author Info
Badkas, Apurva H
Permalink:
http://rave.ohiolink.edu/etdc/view?acc_num=ucin1407410100
Abstract Details
Year and Degree
2014, MS, University of Cincinnati, Engineering and Applied Science: Chemical Engineering.
Abstract
Traditional cancer therapies suffer from toxicity, lack of selectivity, and resistance to drugs. In order to increase the dose reaching the tumor tissue, targeted therapeutic approach is being used. Nanoparticles (NPs) can carry larger amount of drugs, however the amount of these NP systems reaching is less than 10%. Most of these NPs get taken up by cells of the immune system, and segregate in organs of the body such as liver, lungs and spleen. Adding a polymer coating such as Poly ethylene glycol reduces the non-specific uptake. Adding a targeting ligand on the NP surface allows specific interaction with the tumor target and intracellular delivery of the payload. However, the protein coating covers the PEG surface. This study undertakes modification of the antibody of interest (Herceptin) with short PEG moieties. It deals with the characterization of the plain and modified Herceptin and immune response of the mouse macrophage cell line RAW 264.7 to NP-antibody/ NP-modified antibody system. Herceptin and modified Herceptin were characterized using Matrix Assisted Laser Desorption/ Ionization (MALDI) and Mass Spectrometry. Two cytokines, TNF-a and IL-1ß were measured by Enzyme Linked Immuno Sorbent Assay (ELISA). Fluorescent Microscopy study was undertaken. Systematic study of the applicability of the Bradford Assay to the modified antibody was done. Two standard proteins: Bovine Serum Albumin (BSA) and Bovine Gamma Globulin (BGG) were compared with Herceptin response. Modeling of the Herceptin structure was done using the protein sequence available in the Protein databank.
Committee
Joo Youp Lee, Ph.D. (Committee Chair)
Soon Jai Khang, Ph.D. (Committee Member)
Yuet Kin Leung, Ph.D. (Committee Member)
Jagjit Yadav, Ph.D. (Committee Member)
Pages
80 p.
Subject Headings
Chemical Engineering
Keywords
Drug Delivery
;
Immunogenicity
;
NP-Protein
;
Modification
Recommended Citations
Refworks
EndNote
RIS
Mendeley
Citations
Badkas, A. H. (2014).
Modified Antibody for Targeted Drug Delivery and Reduced Immunogenicity
[Master's thesis, University of Cincinnati]. OhioLINK Electronic Theses and Dissertations Center. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1407410100
APA Style (7th edition)
Badkas, Apurva.
Modified Antibody for Targeted Drug Delivery and Reduced Immunogenicity.
2014. University of Cincinnati, Master's thesis.
OhioLINK Electronic Theses and Dissertations Center
, http://rave.ohiolink.edu/etdc/view?acc_num=ucin1407410100.
MLA Style (8th edition)
Badkas, Apurva. "Modified Antibody for Targeted Drug Delivery and Reduced Immunogenicity." Master's thesis, University of Cincinnati, 2014. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1407410100
Chicago Manual of Style (17th edition)
Abstract Footer
Document number:
ucin1407410100
Download Count:
471
Copyright Info
© 2014, all rights reserved.
This open access ETD is published by University of Cincinnati and OhioLINK.